Neutrisci International Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Stock Symbol
  • NU.H

Stock Symbol

  • Investments
  • 3

Neutrisci International General Information

Description

NeutriSci International Inc specializes in the production and formulation of nutraceutical products within the B2B industry. By incorporating natural ingredients, it implements industry disrupting patent pending Cryolization Technology to provide B2B partners with the ability to create unparalleled products. Using patent pending proprietary ingredients, technologies, and IP, it can help bring to market effective, solution-oriented products that meet the needs of consumers. The company continues to develop emerging sales channels in the USA, European, Asian & South American markets.

Contact Information

Formerly Known As
DISANI CAPITAL, HEALTHPRICER INTERACTIVE, OMNITECH CAPITAL, ONE PERSON HEALTH SCIENCES
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 610 Granville Street
  • Suite 1600
  • Vancouver, British Columbia V7Y 1C3
  • Canada
+1 (403)
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
TSX
Corporate Office
  • 610 Granville Street
  • Suite 1600
  • Vancouver, British Columbia V7Y 1C3
  • Canada
+1 (403)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neutrisci International Stock Performance

As of 07-May-2024, Neutrisci International’s current market cap is $653K with 178M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$653K 178M 41.4K

Neutrisci International Financials Summary

As of 30-Sep-2023, Neutrisci International has a trailing 12-month revenue of $44.4K.

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 811 2,050 7,031 15,106
Revenue 44 351 64 56
EBITDA (384) (563) (1,217) (1,434)
Net Income (409) (592) (1,253) (1,455)
Total Assets 94 244 643 414
Total Debt 156 132 47 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Neutrisci International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neutrisci International‘s full profile, request access.

Request a free trial

Neutrisci International Patents

Neutrisci International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3090713-A1 Compositions comprising co-crystals of stilbenoids and cannabinoids Inactive 09-Feb-2018
US-20200397744-A1 Compositions comprising co-crystals of stilbenoids and cannabinoids Inactive 09-Feb-2018
WO-2019153088-A1 Compositions comprising co-crystals of stilbenoids and cannabinoids Inactive 09-Feb-2018
JP-2021513566-A Compositions containing cocrystals of stilbenoids and cannabinoids Pending 09-Feb-2018
US-D839745-S1 Package Active 09-Oct-2015
To view Neutrisci International’s complete patent history, request access »

Neutrisci International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neutrisci International‘s full profile, request access.

Request a free trial

Neutrisci International Investments & Acquisitions (3)

Neutrisci International’s most recent deal was a Joint Venture with Ambarii Trade. The deal was made on 10-Apr-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ambarii Trade 10-Apr-2017 Joint Venture Drug Discovery
Disani Capital 01-Dec-2014 Merger/Acquisition Other Financial Services
ChromaDex (BluScience) 01-Mar-2013 Merger/Acquisition Surgical Devices
To view Neutrisci International’s complete investments and acquisitions history, request access »

Neutrisci International ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Neutrisci International’s complete esg history, request access »

Neutrisci International FAQs

  • When was Neutrisci International founded?

    Neutrisci International was founded in 2000.

  • Where is Neutrisci International headquartered?

    Neutrisci International is headquartered in Vancouver, Canada.

  • What industry is Neutrisci International in?

    Neutrisci International’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Neutrisci International a private or public company?

    Neutrisci International is a Public company.

  • What is Neutrisci International’s stock symbol?

    The ticker symbol for Neutrisci International is NU.H.

  • What is the current market cap of Neutrisci International?

    The current market capitalization of Neutrisci International is $653K.

  • What is Neutrisci International’s current revenue?

    The trailing twelve month revenue for Neutrisci International is $44.4K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process